The study by Mennini et al.
1. Absolute risk reduction of BP treatment = (probability of BP controljBP treatment) 9 (absolute risk reductionjBP control) 2. Net cost = 10-year cost of BP treatment -(absolute risk reduction of BP treatment) 9 (cost of hospitalization), where absolute risk reduction (ARR) refers to cardiovascular events. With regard to the first equation, Table 1 provides data on the ARR of BP control. In Italy, for example, a favorable estimate for the ARR of BP control is 5.5 % (=10-4.5 %), which holds for females. In addition, based on data in Appendix C, 56.7 % of Italian patients treated are controlled. Hence, the ARR of BP treatment is 3.1 % (5.5 9 56.7 %). Inserting this value in the second equation yields the net cost: 10 9 €280-0.031 9 €3939 = €2677.16. Hence, BP treatment in Italy leads to a net increase in costs. We obtain the same result for the other countries. Therefore, from the reading it is not clear how the authors came up with their finding of savings from adherence improvement. This result is also at odds with the results of cost-effectiveness analyses on BP treatment conducted in England and Germany using the Framingham risk equation as well: they did not show savings except for the treatment of high-risk patients [2, 3] .
